Does adjuvant therapy reduce postmetastatic survival?
نویسندگان
چکیده
منابع مشابه
Does adjuvant radiation therapy improve disease-free survival in completely resected Masaoka stage II thymoma?
OBJECTIVE To determine whether or not patients with completely resected Masaoka stage II thymoma benefit from postoperative radiotherapy (RT). METHODS We retrospectively review the case records and compared the long-term outcomes of patients affected by Masaoka stage II thymoma treated by resection alone with same stage thymoma patients submitted to resection and RT. Surgical specimens were r...
متن کاملProlonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy.
BACKGROUND On the basis of data from a phase 2 trial that compared the checkpoint inhibitor ipilimumab at doses of 0.3 mg, 3 mg, and 10 mg per kilogram of body weight in patients with advanced melanoma, this phase 3 trial evaluated ipilimumab at a dose of 10 mg per kilogram in patients who had undergone complete resection of stage III melanoma. METHODS After patients had undergone complete re...
متن کاملDoes cardiac resynchronization therapy reduce sudden cardiac deaths?
the methods section of guidelines ‘the use of vasodilators should take into account the contraindication of ACE-inhibitors and angiotensin receptor blockers’. We also agree with the reasons detailed in the letter, which, unfortunately, cannot be developed in a document of guidelines format. More generally, if possible, patients with left ventricular ejection fraction ,40% should probably be dis...
متن کاملDoes folate therapy reduce the risk of coronary restenosis?
BACKGROUND.: A high homocysteine level is associated with an increased risk of ischaemic heart disease. Folate therapy has shown to reduce the homocysteine blood level, but does it decrease the risk of coronary restenosis in patients with coronary arterial disease? METHODS.: A systematic online literature search followed by a critical appraisal resulted in three suitable articles to provide an ...
متن کاملDoes directly observed therapy (DOT) reduce drug resistant tuberculosis?
BACKGROUND Directly observed therapy (DOT) is a widely recommended and promoted strategy to manage tuberculosis (TB), however, there is still disagreement about the role of DOT in TB control and the impact it has on reducing the acquisition and transmission of drug resistant TB. This study compares the portion of drug resistant genotype clusters, representing recent transmission, within and bet...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2019
ISSN: 0923-7534
DOI: 10.1093/annonc/mdz159